investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Personalized Nanomedicines for Leukemia Patients

Investigator from Hannover Medical School

0 Collaborator(s)

Funding source

European Commission (Belgium)

Related projects

Dean W Felsher

Mechanisms by which Oncogene Inactivation Elicits Tumor Cell Death

Sarcoma Liver and intrahepatic bile ducts Leukaemia

Gerd P Pfeifer

5-hydroxymethylcytosine in Human Cancer

Leukaemia Brain, nervous system

Peter Aplan

Activation of Proto-Oncogenes by Chromosomal Translocation

Leukaemia

Hematology and hematologic malignancies Pathology

Becca Asquith

KIR in adaptive immunity: in vivo relevance for human disease

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Elizaveta V Benevolenskaya

RBP2 Regulation Through Differential Recruitment to Genomic Loci

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Denis Lacombe

EORTC Headquarters

Trachea, bronchus and lung Prostate Pancreas Ovary Other pharynx Oesophagus Non-Hodgkin lymphoma Nasopharynx Liver and intrahepatic bile ducts Leukaemia Kidney, renal pelvis and ureter Corpus uteri Colorectum Cervix uteri Breast Brain, nervous system

Hongbo Chi

Tsc1/mTOR axis in immune homeostasis and tumorigenesis

Leukaemia

Christopher Y Park

Cellular and molecular basis of microRNA-29a Induced Acute Myeloid Leukemia

Leukaemia

Aaron David Schimmer

Inhibiting oncogenic kinases to target metabolism in AML

Leukaemia